The U.S. FDA approved a pricey rare disease drug in September despite findings by its data reviewers that the treatment, ...
The intravenous formulation of fosfomycin has a novel mechanism of action an no known cross-resistance to other antibiotic ...
The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven ...
The U.S. Food and Drug Administration has approved Lynkuet, a new medication that does not contain hormones to treat hot ...
Treatments for asthma, chronic rhinosinusitis with nasal polyps, dyslipidemia, Cushing syndrome, gonorrhea, HSCT-associated thrombotic microangiopathy, marginal zone lymphoma, motion sickness, ...
There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...
Elinzanetant belongs to a new class of drugs designed to target what is believed to be a key mechanism responsible for ...
Ironwood Pharmaceuticals (IRWD) stock gains as the FDA approves a label expansion for the company's AbbVie (ABBV)-partnered ...
The Food and Drug Administration has approved a new non-hormonal pill to treat hot flashes and night sweats brought on by ...
The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to severe hot flashes in menopausal women, drugmaker Bayer said Friday. The drug, ...